PIVCs with extension sets can include one or more flow diverting features for maximizing the amount of flushing that occurs within the interior of the catheter adapter. These flow diverting features can therefore minimize the amount of residual blood, medicament, or other fluid that may exist within the catheter adapter after the PIVC has been flushed via the extension set. The flow diverting features may be in the form of structural modifications to the side port of the extension set, separate components that are contained within the side port or catheter adapter, integrated components within the side port or catheter adapter, other features or some combination of any of these features.

A system and method is provided for applying an anti-pathogenic material to various surfaces of a medical device, wherein the method includes identifying various surfaces of the medical tests which include noncritical dimensions, and limiting the application of the anti-pathogenic material to those surfaces. Some aspects of the invention further include the application of an anti-pathogenic lubricant material to various parts or components of a medical device to reduce friction.

In various embodiments, implants including reservoirs, such as intraocular lenses, feature flexible membranes and valves integrated therewith, the valves having apertures that are normally closed.

Described is a low voltage, pulsed electrical stimulation device for controlling expression of, for example, follistatin, a muscle formation promotion protein, by tissues. Epicardial stimulation is especially useful for heart treatment. Follistatin controlled release is also useful for treating other ailments, such as erectile dysfunction, aortic aneurysm, and failing heart valves.

A device (1) for dispensing a fluid, in particular under aseptic conditions, preferably to a patient. The device comprises a conveying device (2) for conveying the fluid to a dispensing opening (3). The device (1) also comprises a coupling element (4) for coupling a syringe (5). The fluid can be conveyed from the syringe (5) to the dispensing opening (3) via the coupling element (4) and the conveying device (2) exclusively by the effect of the conveying device (2). The invention further relates to a system for dispensing a fluid under aseptic conditions, comprising such a device (1) and to a syringe (5) that can be coupled to the coupling element (4).

Disclosed is septum arrangement having a pierceable septum. The pierceable septum has first and second surfaces positioned opposite to one another and a peripheral surface. A compression element has at least two compression members that partially or fully surround the peripheral surface and has at least two gripping members. Each compression member is connected to at least one gripping member, and the gripping members extend from the compression members towards a common axis (A) which intersects the first surface. A resilient element exerts a biasing force on the pierceable septum that is directed towards the common axis (A). The gripping members define an aperture between them such that introduction of a needle into the aperture exerts a force on the gripping members that counteracts the biasing force and moves the gripping members apart from each other.

A power supply device includes a power transmission coil which supplies electric power from outside the body in a non-contact manner via a power reception coil of an intracorporeal implanting-type medical appliance to which a drug solution is injected from outside the body. A support supports the power transmission coil, and an adhesive part is formed on the side of the support facing the body surface of a living subject.

Valve assemblies having improved ability to selectively control flow of fluids through the catheter and prevent leakage of fluids from the proximal end of a catheter that is positioned within a patient. Such improved catheter valve assemblies also prevent leakage of fluids after repeated insertion and removal of medical instruments through the valve.

Drug delivery devices, sealing members for containers housed within such drug delivery devices, and related methods of assembly are disclosed. The drug delivery device may include a housing, a container disposed in the housing and having an interior volume, a drug disposed in the interior volume, and a septum. The container may have an opening formed in an end surface and which communicates with the interior volume. The septum may include a proximal end inserted through the opening into the interior volume of the container. Additionally, the septum may include a distal end having a flange disposed outwardly of the proximal end and contacting the end surface of the container. At least an end portion of the flange may be made of a material that is permeable to a gaseous sterilizing agent.

A vascular access site management system includes a stabilization body and a flow housing that is rotatable relative to the stabilization body. The flow housing may have a flow path extending through it to allow fluids to be introduced into or extracted from a patient via a catheter connected to the vascular access site management system. The vascular access site management system may also include a needle free connector fluidly connected to the flow housing via a section of tubing.